HAND & WRIST
Triamcinolone has a rapid but short lasting effect in idiopathic trigger finger
This report has been verified
by one or more authors of the
original publication.
J Hand Surg Am. 2008 Apr;33(4):516-22; discussion 523-4.
84 patients (>18 years) with idiopathic trigger finger were randomized to receive either dexamethasone or triamcinolone injection, to determine which treatment was better in resolving triggering symptoms. Although no statistically significant differences between the 2 treatments were seen at 3 months after injection, a trend was noticed suggesting that triamcinolone had a rapid but short lasting effect on idiopathic trigger finger compared to dexamethasone injection.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
